Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | MAPK9 |
| Gene Name: | MAPK9 |
| Protein Full Name: | Mitogen-activated protein kinase 9 |
| Alias: | C-Jun N-terminal kinase 2; EC 2.7.11.24; JNK2-alpha-2; JNK-55; Jun kinase; Kinase JNK2; MAPK9; MK09; P54a; P54-alpha; PRKM9; SAPK; SAPK-alpha; Stress-activated protein kinase JNK2 |
| Mass (Da): | 48139 |
| Number AA: | 424 |
| UniProt ID: | P45984 |
| Locus ID: | 5601 |
| COSMIC ID: | MAPK9 |
| Gene location on chromosome: | 5q35 |
| Cancer protein type: | TSP |
| Effect of cancer mutation on protein: | UNCLEAR |
| Effect of active protein on cancer: | INHIBITS |
| Number of cancer specimens: | 20594 |
| Percent of cancer specimens with mutations: | 0.38 |
| Normal role description: | MAPK9 is a protein-serine/threonine kinase. It is involved in cell proliferation, differentiation, apoptosis, migration, transcriptional regulation and development in response to stress and cytokines. It has also been implicated in preventing ubiquitination of p53. |